CLASS III Device recall · Reported 5 Jul 2017 · FDA Enforcement Report

Diastat(R) Ana (anti-Nuclear antibody) Euro Diagnostica recalled

Euro Diagnostica AB is recalling Diastat(R) Ana (anti-Nuclear antibody) Euro Diagnostica, The Diastat(R) anti-nuclear, distributed in Minnesota, Nebraska, Pennsylvania, Texas. The recall was initiated on 22 May 2017 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesTS 3577
Quantity recalled501 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2627-2017
FDA event ID
77426
Recalling firm
Euro Diagnostica AB, Malmo, N/A
Classification
Class III
Status
Terminated
Recall initiated
22 May 2017
FDA classified
23 Jun 2017
Reported
5 Jul 2017
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

22 May 2017Recall initiated by company
23 Jun 2017Classified by FDA+32 days
5 Jul 2017Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

FANA200 kit lot TS 3577 was re-worked due to shortened shelf-life. The alert sticker on the kit box of the lot informed customers that the shelf-life had been shortened and referenced a letter sent to customers for more information, where the new expiration date was stated. The original kit box label remained on the kit box stating the original expiration date, the packaging did not display the correct expiration date.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

DIASTAT(R) ANA (anti-Nuclear antibody) EURO DIAGNOSTICA, The DIASTAT(R) anti-nuclear antibody (ANA) test is a qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of ANAs in human serum or EDTA plasma. It detects ANAs against Sm, Sm/RNP, Ro (SS-A), La (SS-B), Scl-70, Jo-1, dsDNA, histone and centromere antigens.

Where it was distributed

MN, TX, NE, PA, Spain, Egypt, Pakistan, Nepal, Canada

MinnesotaNebraskaPennsylvaniaTexas

Questions about this recall

Why was it recalled?

FANA200 kit lot TS 3577 was re-worked due to shortened shelf-life. The alert sticker on the kit box of the lot informed customers that the shelf-life had been shortened and referenced a letter sent to customers for more information, where the new expiration date was stated. The original kit box label remained on the kit box stating the original expiration date, the packaging did not display the correct expiration date.

Which lots are affected?

TS 3577

Where was it sold?

MN, TX, NE, PA, Spain, Egypt, Pakistan, Nepal, Canada

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Euro Diagnostica AB

All 8

Other Test Kits & Diagnostics recalls

All 2,656